Myelodysplastic Syndrome/Acute Myeloid Leukemia Follow-Up Study

Contact: Sara Strom, Ph.D.

Number of Enrolled Cancer Patients/Survivors:	2,000
Years of Diagnoses of Enrolled Cancer Patients/Survivors:	2002
Approximate Years of Follow-up:	Mean 6 years
Cancer Sites Represented:	Leukemias
Biological Specimens Collected:	Blood Germline DNA
Treatment Outcome Measures:	Physician/Medical Record Reported Cancer Recurrence Death Patient-Reported Late Medical Event Cancer Recurrence Death
Co-morbidities at Study Entry:	None
Lifestyle Factors:	Smoking Alcohol Use Diet Physical Activity Body Mass Index
Treatment Data:	Surgery Radiation Chemotherapy Hormonal Therapy Bone Marrow/Stem Cell Transplant
Treatment Data Assessed By:	Electronic Record Chart Abstraction Patient Reported Questionnaire
Is the study open to collaboration?	Yes